Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:ATCCode |
none (as of 2024)
|
| gptkbp:CASNumber |
1448221-48-6
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
GlycoMimetics, Inc.
|
| gptkbp:hasMolecularFormula |
C29H38N4O13
|
| gptkbp:hasUNII |
6Q1K1Q1K0E
|
| https://www.w3.org/2000/01/rdf-schema#label |
Uproleselan
|
| gptkbp:investigatedBy |
gptkb:acute_myeloid_leukemia
|
| gptkbp:IUPACName |
(2R,3R,4R,5R,6R)-2-(acetylamino)-6-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-3-carboxylic acid
|
| gptkbp:mechanismOfAction |
E-selectin antagonist
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL4297592
86278336 DB15063 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
GMI-1271
|
| gptkbp:target |
gptkb:E-selectin
|
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|